Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in NK Cells
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
NK cells are defective in acute myeloid Leukemia (AML) at diagnosis. Here we studied the kinetic of expression of the major activating and inhibitory receptors of NK, CD8 T and γδ T cells in patients undergoing chemotherapy (CT) for the treatment of AML (n=29). We show that NK cells are the main affected population at diagnosis and that expression of activating receptors is partially restored within a few weeks after CT. CD8 T cells and γδ T cells are only weakly affected at diagnosis. KIR expression by NK cells, but not NKG2A and CD85j, was down regulated. Interestingly, the development of NK cells appeared altered as the most immature CD56bright NK cells were seriously under represented. Finally, we showed that NK cells functions were only partially restored 6 weeks after CT as degranulation capabilities of NK cells recovered whereas cytokine production remained low. Our data point out NK cells as anti-tumor effectors peculiarly hampered by leukemic cells. This study may indicate a timeline when NK-mediated therapies or other immunotherapies could be performed, particularly for patients excluded of hematopoietic stem cell transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380 · cited 1×
“NK cell importance in leukemia control has been evidenced by the pioneering study of Ruggeri and was followed since by many centers (8, 9).”
BackgroundLopez-Vergès, S., Milush, J. M., Pandey, S., York, V. A., Arakawa-Hoyt, J., Pircher, H., Norris, P. J., Nixon, D. F., & Lanier, L. L. (2010) · Blood · doi:10.1182/blood-2010-04-282301 · Cited by 752
Fauriat, C., Just-Landi, S., Mallet, F., Arnoulet, C., Sainty, D., Olive, D., & Costello, R. T. (2007) · Blood · doi:10.1182/blood-2005-08-027979 · Cited by 380
Self-citation
Cited by
Mikulak, J., Bruni, E., Oriolo, F., Di Vito, C., & Mavilio, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00946 · Cited by 145
Targeting the immune microenvironment in acute myeloid leukemia: a focus on T cell immunity
Lamble, A. J., & Lind, E. F. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00213 · Cited by 119
“Interestingly, this increase normalized following the administration of chemotherapy (24).”
BackgroundKinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer
Dorta-Estremera, S., Colbert, L. E., Nookala, S. S., Yanamandra, A. V., Yang, G., Delgado, A., Mikkelson, M., Eifel, P., Jhingran, A., Lilie, L. L., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.06.404 · Cited by 48
“(21, 22) In our study, we observed that this decline is more profound in the cervix, specifically after 1 week of treatment, but these cells are recovered after 5 weeks of treatment, reaching levels similar to baseline.”
Background
Metadata
- Authors
- Rey, J., Fauriat, C., Kochbati, E., Orlanducci, F., Charbonnier, A., D’Incan, E., Andre, P., Romagne, F., Barbarat, B., Vey, N., & Olive, D.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-02-02
- Volume
- 8
- Pages
- 64-64
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2583497199
- Cited by
- 51
- References
- 3
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.